Search By Initial

Cas Index 1

• 1173699-31-4 | AMG-337 (Catalog# : 01181)AMG-337 is a potent and highly selective small molecule ATP-competitive MET kinase in
• 1047644-62-1 | Afuresertib (Catalog# : 011811)Afuresertib is a potent pan-AKT inhibitor that demonstrated synergy with bortezomib i
• 1422731-37-0 | APTO-253 (Catalog# : 011802)APTO-253 is a small molecule inhibitor of human metal-regulatory transcription factor
• 1258392-53-8 | AZD-5582 (Catalog# : 011117)AZD5582 is a potent IAP inhibitor, which is a dimeric compound based on the AVPI moti
• 131707-23-8 | Arbidol hydrochloride (Catalog# : 011111)Arbidol is an broad-spectrum antiviral chemical agent which can inhibit cell entry of
• 1216665-49-4 | APY29 (Catalog# : 011108)APY29 is an allosteric modulator of IRE1; inhibits IRE1 autophosphorylation (IC50 = 2
• 1228237-57-7 | ARQ-736 (Catalog# : 011104)ARQ 736 is a potent and selective BRAF inhibitor.
• 1035270-39-3 | AZD4547 (Catalog# : 010820)AZD4547 is a novel selective FGFR inhibitor targeting FGFR1/2/3 with IC50 of 0.2 nM/2
• 1236699-92-5 | AS703026 (Catalog# : 010808)AS703026 is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2)
• 1035227-43-0 | AZ505 (Catalog# : 010803)AZ505 is a potent and highly selective inhibitor of the oncogenic protein SMYD2(IC50=
• 154323-57-6 | Almotriptan (Catalog# : 010418)Almotriptan is a 5-HT1B/1D-receptor agonist used to treat migraine.
• 164178-33-0 | AM630 (Catalog# : 010410)AM630 is a selectivity CB2 antagonist with Ki of 31.2 nM; > 150 fold selectivity o
• 1009298-09-2 | AZD-8055 (Catalog# : 123019)AZD-8055 is an inhibitor of the mammalian target of rapamycin (mTOR) with potential a
• 1627494-13-6 | AZD8186 (Catalog# : 122925)AZD8186 is an isoform-specific small-molecule PI3K inhibitor, potently inhibits PI3K
• 1448346-63-1 | AG-120 (Catalog# : 122906)AG-120 is an orally available inhibitor of isocitrate dehydrogenase type 1 (IDH1), wi
• 1034148-04-3 | AZD-5423 (Catalog# : 122902)Coming soon!
• 183232-66-8 | AM251 (Catalog# : 122842)AM251 is a potent CB1 receptor antagonist (IC50 = 8 nM, Ki = 7.49 nM) that displays 3
• 134523-01-6 | Atorvastatin sodium (Catalog# : 122303)Atorvastatin has the potential to ameliorate arsenic-induced vascular dysfunction and
• 110267-81-7 | Amrubicin (Catalog# : 122211)Amrubicin is a novel anthracycline derivative for treatment of bladder carcinoma.
• 134036-52-5 | AG 490 (Catalog# : 122210)AG-490 is a tyrosine kinase inhibitor of JAK2, EGFR, and Neu that belongs to the fami
• 121268-17-5 | Alendronate sodium trihydrate (Catalog# : 120409)Coming soon!
• 1345847-93-9 | Altiratinib (Catalog# : 120104)Altiratinib is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden i
• 1355326-35-0 | AGI-5198 (Catalog# : 120103)AGI-5198 is a novel R132H-IDH1 inhibitor, identified through a high-throughput screen
• 1166227-08-2 | A66 (Catalog# : 120101)A66 is a potent and specific p110 inhibitor with IC50 of 32 nM, >100 fold selectiv
• 1352226-88-0 | AZD6738 (Catalog# : 110906)AZD6738 is an orally available morpholino-pyrimidine-based inhibitor of ataxia telang
• 106447-97-6 | 2-Amino-4-(trifluoromethyl)pyridine (Catalog# : 110214)Coming soon!
• 141430-65-1 | ABT-751 (Catalog# : 102613)ABT-751 is a novel bioavailable tubulin-binding and antimitotic sulfonamide agent wit
• 1613393-51-3 | (3aR,5S)-3a,4,5,7-tetrahydro-5-methyl-3H-pyrano[3,4-c]isoxazole (Catalog# : 91823)Coming soon!
• 1220327-45-6 | (3aR,5R)-3a,4,5,7-tetrahydro-5-methyl-3H-pyrano[3,4-c]isoxazole (Catalog# : 91803)Coming soon!
• 14166-28-0 | (3aR,4S,7R,7aS)-Hexahydro-4,7-methanoisobenzofuran-1,3-dione (Catalog# : 91404)The related APILurasidone hydrochlorideThe related intermediates4-(1,2-Benzothiazol-3